Categories
Listings
Results 1 - 17 of 17
ABL Kinase Gene Mutation Analysis and Gleevec® Resistan... Featured
Category:Chronic Myelogenous Leukemia (CML)
Test CodeABL G
AssociationsChronic myelogenous leukemia (CML), Acute lymphoblastic leukemia (ALL), Allogeneic bone marrow transplantation, Minimal residual disease (MRD), Molecular remission, Gleevec® resistance
MethodologyQuantitative reverse transcriptase PCR (RT-PCR), Semi-nested PCR, Bi-directional DNA sequencing
Testing is performed at MolecularMD of Portland, Oregon pursuant to patents.
Acetylcholinesterase
Category:Prenatal Diagnostics
Test CodeACHE
AssociationsNeural tube defect
MethodologyGel electrophoresis
Acute Lymphoblastic Leukemia (ALL) Adult Profile Featured
Category:Acute Lymphoblastic Leukemia (ALL)
Test CodeF AALL
AssociationsAcute lymphoblastic leukemia (ALL)
MethodologyFluorescence in situ Hybridization (FISH)
Acute Lymphoblastic Leukemia (ALL) Pediatric Profile Featured
Category:Acute Lymphoblastic Leukemia (ALL)
Test CodeF PALL
AssociationsAcute lymphoblastic leukemia (ALL)
MethodologyFluorescence in situ Hybridization (FISH)
Akt, Protein Kinase B by IHC
Category:Immunohistochemistry markers
Test CodeI AKT
AssociationsA member of the Akt serin/threonine protein kinase family.
Proliferation marker
MethodologyImmunohistochemistry. Clone LP18
ALK 2p23 gene rearrangement Featured
Category:Lymphoma
Test CodeF ALK
AssociationsNSCLC with ALK gene rearrangements can now be treated with Xalkori (crizotinib), FDA approved for late stage locally advanced or metastatic NSCLC.
MethodologyFluorescence in situ Hybridization (FISH)
ALK Anaplastic Lymphoma Kinase -1
Category:Immunohistochemistry markers
Test CodeI ALK
AssociationsAnaplastic large cell Lymphoma
MethodologyImmunohistochemistry
Alphafetoprotein (amniotic fluid)
Category:Prenatal Diagnostics
Test CodeAF AFP
AssociationsNeural tube defect
MethodologyChemiluminescent Immunoassay / Electrophoresis
AML Mutational Analysis Profile
Category:Mutation Analysis
Test CodeP AML
AssociationsAcute Myelogenous Leukemia (AML)
MethodologyPolymerase Chain Reaction (PCR), Gene amplification of FLT3 (exons 14 and 15) and NPM1 (exon 12) with fluorescently-labeled primers followed by detection with capillary electrophoresis
Testing for FLT3 will be performed at Laboratory for Personalized M ...
AML1/ETO t(8;21)
Category:Acute Myeloid Leukemia (AML)
Test CodeF AML ETO
AssociationsAcute myelogenous leukemia, AML(M2)
MethodologyFluorescence in situ Hybridization (FISH)
AneuVysion®: +13, +18, +21, X, Y
Category:Constitutional
Test CodeF ANEU
AssociationsTrisomy 13, trisomy 18, trisomy 21, aneuploidy X or Y
MethodologyFluorescence in situ Hybridization (FISH)
Angelman Syndrome
Category:Constitutional
Test CodeF AS
AssociationsAngelman Syndrome
MethodologyFluorescence in situ Hybridization (FISH)
Anti-Caldesmon
Category:Immunohistochemistry markers
Test CodeI CALDSM
MethodologyImmunohistochemistry
API2/MALT1 t(11;18)
Category:Lymphoma
Test CodeF API MALT
AssociationsMALT lymphoma, Non-Hodgkin (NHL), Extranodal marginal zone B-cell lymphoma
MethodologyFluorescence in situ Hybridization (FISH)
Apoptosis / Cell Cycle Progression by Immunohistochemis...
Category:Immunohistochemistry groups
AssociationsI P21WAF: p21 waf, WAF1, inhibitory gene
I P27KIP: p27Kip, kinase inhibitory protein 1
P PERK1/2: pERK1/2, extracellular signal related kinase
I PRB: pRb, phosphorylated retiniblastoma suppressor protein
MethodologyImmunohistochemistry
ATM deletion 11q22.3
Category:Chronic Lymphocytic Leukemia (CLL)
Test CodeF ATM
AssociationsChronic lymphocyctic leukemia (CLL)
MethodologyFluorescence in situ Hybridization (FISH)
Results 1 - 17 of 17